U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C22H26ClN7O2S
Molecular Weight 488.006
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DASATINIB ANHYDROUS

SMILES

CC1=NC(NC2=NC=C(S2)C(=O)NC3=C(Cl)C=CC=C3C)=CC(=N1)N4CCN(CCO)CC4

InChI

InChIKey=ZBNZXTGUTAYRHI-UHFFFAOYSA-N
InChI=1S/C22H26ClN7O2S/c1-14-4-3-5-16(23)20(14)28-21(32)17-13-24-22(33-17)27-18-12-19(26-15(2)25-18)30-8-6-29(7-9-30)10-11-31/h3-5,12-13,31H,6-11H2,1-2H3,(H,28,32)(H,24,25,26,27)

HIDE SMILES / InChI

Approval Year

Unknown
86413
Name Type Language
DASATINIB ANHYDROUS
Common Name English
BMS-354825
Code English
5-THIAZOLECARBOXAMIDE, N-(2-CHLORO-6-METHYLPHENYL)-2-((6-(4-(2-HYDROXYETHYL)-1-PIPERAZINYL)-2-METHYL-4-PYRIMIDINYL)AMINO)-
Systematic Name English
dasatinib [INN]
Common Name English
Dasatinib [WHO-DD]
Common Name English
DASATINIB [MI]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C155700
Created by admin on Fri Dec 15 16:26:51 UTC 2023 , Edited by admin on Fri Dec 15 16:26:51 UTC 2023
NCI_THESAURUS C1967
Created by admin on Fri Dec 15 16:26:51 UTC 2023 , Edited by admin on Fri Dec 15 16:26:51 UTC 2023
NDF-RT N0000175605
Created by admin on Fri Dec 15 16:26:51 UTC 2023 , Edited by admin on Fri Dec 15 16:26:51 UTC 2023
WHO-ATC L01XE06
Created by admin on Fri Dec 15 16:26:51 UTC 2023 , Edited by admin on Fri Dec 15 16:26:51 UTC 2023
NDF-RT N0000175076
Created by admin on Fri Dec 15 16:26:51 UTC 2023 , Edited by admin on Fri Dec 15 16:26:51 UTC 2023
Code System Code Type Description
RXCUI
1546019
Created by admin on Fri Dec 15 16:26:51 UTC 2023 , Edited by admin on Fri Dec 15 16:26:51 UTC 2023
PRIMARY RxNorm
NDF-RT
N0000182141
Created by admin on Fri Dec 15 16:26:51 UTC 2023 , Edited by admin on Fri Dec 15 16:26:51 UTC 2023
PRIMARY Cytochrome P450 3A4 Inhibitors [MoA]
MERCK INDEX
m4101
Created by admin on Fri Dec 15 16:26:51 UTC 2023 , Edited by admin on Fri Dec 15 16:26:51 UTC 2023
PRIMARY Merck Index
NCI_THESAURUS
C74556
Created by admin on Fri Dec 15 16:26:51 UTC 2023 , Edited by admin on Fri Dec 15 16:26:51 UTC 2023
PRIMARY
EPA CompTox
DTXSID4040979
Created by admin on Fri Dec 15 16:26:51 UTC 2023 , Edited by admin on Fri Dec 15 16:26:51 UTC 2023
PRIMARY
EVMPD
SUB23322
Created by admin on Fri Dec 15 16:26:51 UTC 2023 , Edited by admin on Fri Dec 15 16:26:51 UTC 2023
PRIMARY
CHEBI
49375
Created by admin on Fri Dec 15 16:26:51 UTC 2023 , Edited by admin on Fri Dec 15 16:26:51 UTC 2023
PRIMARY
PUBCHEM
3062316
Created by admin on Fri Dec 15 16:26:51 UTC 2023 , Edited by admin on Fri Dec 15 16:26:51 UTC 2023
PRIMARY
INN
8712
Created by admin on Fri Dec 15 16:26:51 UTC 2023 , Edited by admin on Fri Dec 15 16:26:51 UTC 2023
PRIMARY
DRUG BANK
DB01254
Created by admin on Fri Dec 15 16:26:51 UTC 2023 , Edited by admin on Fri Dec 15 16:26:51 UTC 2023
PRIMARY
CAS
302962-49-8
Created by admin on Fri Dec 15 16:26:51 UTC 2023 , Edited by admin on Fri Dec 15 16:26:51 UTC 2023
PRIMARY
DAILYMED
X78UG0A0RN
Created by admin on Fri Dec 15 16:26:51 UTC 2023 , Edited by admin on Fri Dec 15 16:26:51 UTC 2023
PRIMARY
FDA UNII
X78UG0A0RN
Created by admin on Fri Dec 15 16:26:51 UTC 2023 , Edited by admin on Fri Dec 15 16:26:51 UTC 2023
PRIMARY
SMS_ID
100000088015
Created by admin on Fri Dec 15 16:26:51 UTC 2023 , Edited by admin on Fri Dec 15 16:26:51 UTC 2023
PRIMARY
METABOLITE ACTIVE (PARENT)
Structure of N-DESHYDROXYETHYL DASATINIB
METABOLITE ACTIVE (PARENT)
Structure of BMS-748730
SALT/SOLVATE (PARENT)
Structure of Dasatinib Laurylsulfate
SALT/SOLVATE (PARENT)
Structure of DASATINIB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966